News and Trends 26 Feb 2018
ASIT Biotech Raises €13.9 M to Develop Allergy Immunotherapies
ASIT Biotech, a Belgian company specialized in allergy immunotherapy, raised a total of €13.9M to develop immunotherapies against against grass…
Circassia
- Latest Posts
News and Trends 7 Sep 2017
Circassia Moves Away from a Failed Allergy Pipeline with Phase III Success
Circassia has positive Phase III results from its respiratory pipeline, great news for the company after abandoning its allergy immunotherapies…
News and Trends 18 Apr 2017
Circassia Freezes its Allergy Portfolio after a Second Failed Clinical Trial
Circassia Pharmaceuticals will stop investing in its allergy programs due to two failed clinical trials in which the placebo beat…
News and Trends 17 Mar 2017
Can this British Biotech Overcome Failure buying drugs from AstraZeneca?
After the big disaster with its cat allergy vaccine, Circassia closes a €214M deal to acquire rights from two AstraZeneca…
ADVERTISEMENT
News and Trends 23 Dec 2016
The 8 Biggest Biotech Medical Fails of 2016 in Europe
Although 2016 has brought plenty of good news in medical advances, biotech is an industry where failure is part of…
News and Trends 6 Jul 2016
June was a Tough Month for European Biotech… #Fail
Abivax, Celyad, Circassia and Genticel - these are all European Biotechs that took a hit after failing key clinical trials…
News and Trends 21 Jun 2016
Allergy Immunotherapy Knocked Out in Phase III by an ‘Overperforming Placebo’
Circassia's pipeline takes a major step back as its therapy for cat allergy gets disappointing results -- it had the…
News and Trends 31 May 2016
UK Immunotherapy against Grass Allergies moves on to Phase III Trials
Circassia is beginning a Phase III trial for its short-course immunotherapy for grass allergies. This common type of allergy can…
News and Trends 14 Aug 2015
It’s raining cash, Woodford invested more than 75% of its mega €1.1Bn Biotech fund
Cash is floating into Biotech like never before, in the US as well as in Europe. And Woodford just announced…
News and Trends 6 Feb 2015
2014, the Biggest Year Ever for European Biotech IPOs
There is no need to say it: biotechnology is the latest trend. A worldwide bio-boom has shaken stock markets throughout…
